Related references
Note: Only part of the references are listed.Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health
Daniel Wolff et al.
BONE MARROW TRANSPLANTATION (2021)
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease
Lauren M. Curtis et al.
BLOOD (2021)
ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease
Madan Jagasia et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
Corey Cutler et al.
BLOOD (2021)
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers
Sophie Paczesny et al.
BLOOD ADVANCES (2021)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report
Joseph Pidala et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report
Kirsten M. Williams et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Carfilzomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Pilot Phase II Trial
Joseph Pidala et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study
Virginia Esamilla Gomez et al.
BONE MARROW TRANSPLANTATION (2020)
Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host disease
Saurabh Chhabra et al.
LEUKEMIA & LYMPHOMA (2020)
The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease
Tamim Alsuliman et al.
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE (2020)
IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
Anna-Sophia Kattner et al.
ANNALS OF HEMATOLOGY (2020)
Long-term outcomes of ruxolitinib therapy in steroid-refractory graft-versus-host disease in children and adults
I. S. Moiseev et al.
BONE MARROW TRANSPLANTATION (2020)
Chronic Graft Versus Host Myopathies: Noninflammatory, Multi-Tissue Pathology With Glycosylation Disorders
Alan Pestronk
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)
Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant A Nonrandomized Clinical Trial
Pamela Stratton et al.
JAMA ONCOLOGY (2020)
Ixazomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Phase II Trial
Joseph Pidala et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria)
A. Olivieri et al.
BONE MARROW TRANSPLANTATION (2020)
Management and long-term consequences of genital graft versus host disease following hematopoietic stem cell transplantation
Ahinoam Lev-Sagie et al.
BONE MARROW TRANSPLANTATION (2020)
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack et al.
Lancet Haematology (2020)
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Challenging and Practical Aspects of Nutrition in Chronic Graft-versus-Host Disease
Andrea Z. Pereira et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions
Nathaniel Edward Bennett Saidu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213)
Corey Cutler et al.
BLOOD (2020)
Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia
Yoshihiro Inamoto et al.
BLOOD ADVANCES (2020)
Insights into the role of the JAK/STAT signaling pathway in graft-versus-host disease
Ramzi Abboud et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2020)
Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease
Badri Modi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
How I treat refractory chronic graft-versus-host disease
Stefanie Sarantopoulos et al.
BLOOD (2019)
Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation
Sameem Abedin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study
Edmund K. Waller et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Epidemiology and Real-World Treatment of Chronic Graft-Versus-Host Disease Post Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis
Carlos R. Bachier et al.
BLOOD (2019)
Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children
Jennifer S. Whangbo et al.
BLOOD ADVANCES (2019)
Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease
Roger Belizaire et al.
BLOOD ADVANCES (2019)
Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD
Madan Jagasia et al.
BLOOD ADVANCES (2019)
Long-Term Topical Diquafosol Tetrasodium Treatment of Dry Eye Disease Caused by Chronic Graft-Versus-Host Disease: A Retrospective Study
Mio Yamane et al.
EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE (2018)
Lung transplantation for bronchiolitis obliterans syndrome after allogenic hematopoietic stem cell transplantation
Fei Gao et al.
FRONTIERS OF MEDICINE (2018)
A prospective study of female genital chronic graft-versus-host disease symptoms, signs, diagnosis and treatment
Eva Smith Knutsson et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2018)
Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis
Fevzi F. Yalniz et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease
George L. Chen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
A Prospective Trial of Extracorporeal Photopheresis for Chronic Graft-versus-Host Disease Reveals Significant Disease Response and No Association with Frequency of Regulatory T Cells
Jocelyn S. Gandelman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease
Myrna R. Nahas et al.
BLOOD (2018)
EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
Helene M. Schoemans et al.
BONE MARROW TRANSPLANTATION (2018)
Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center
Aliana Meneses Ferreira et al.
BONE MARROW TRANSPLANTATION (2018)
Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease
Hanna Jean Khoury et al.
BONE MARROW TRANSPLANTATION (2018)
Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib
Lotte van der Wagen et al.
BONE MARROW TRANSPLANTATION (2018)
A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801
Paul A. Carpenter et al.
HAEMATOLOGICA (2018)
Autologous blood as a source of platelet gel for the effective and safe treatment of oral chronic graft-versus-host disease
Ines Bojanic et al.
TRANSFUSION (2018)
A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801
Paul A. Carpenter et al.
HAEMATOLOGICA (2018)
Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation
Yoshihiro Inamoto et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
An early increase of CD56(bright) natural killer subset as dominant effect and predictor of response to extracorporeal photopheresis for graft-versus-host disease
Pastora Iniesta et al.
TRANSFUSION (2018)
Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study
Ioanna Sakellari et al.
JOURNAL OF CLINICAL APHERESIS (2018)
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
L. Giaccone et al.
BONE MARROW TRANSPLANTATION (2018)
How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
Kirsten M. Williams
BLOOD (2017)
Long-term safety and efficacy of autologous platelet lysate drops for treatment of ocular GvHD
S. Pezzotta et al.
BONE MARROW TRANSPLANTATION (2017)
Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease
Amir A. Azari et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2017)
Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease
C. Hurabielle et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
David Miklos et al.
BLOOD (2017)
Phase 1 study of the Hedgehog pathway inhibitor sonidegib for steroid-refractory chronic graft-versus-host disease
Zachariah DeFilipp et al.
BLOOD ADVANCES (2017)
A Pilot Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-Associated Ocular Surface Disease
Ahmad Kheirkhah et al.
CORNEA (2017)
Clinical management of genital chronic GvHD
B. K. Hamilton et al.
BONE MARROW TRANSPLANTATION (2017)
Scleral lenses for severe chronic GvHD-related keratoconjunctivitis sicca: a retrospective study by the SFGM-TC
L. Magro et al.
BONE MARROW TRANSPLANTATION (2017)
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease
Kenneth R. Cooke et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Phase-1/-2 study of pomalidomide in chronic GvHD
I. Pusic et al.
BONE MARROW TRANSPLANTATION (2016)
A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation
Sally Arai et al.
CLINICAL CANCER RESEARCH (2016)
Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease
Filip Pirsl et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host Disease
Nathaniel Treister et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation
Kirsten M. Williams et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease
Francesco Zallio et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease
John Koreth et al.
BLOOD (2016)
Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation
C. Del Fante et al.
BONE MARROW TRANSPLANTATION (2016)
A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease
Tulio B. Abud et al.
OPHTHALMOLOGY (2016)
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo
Michele Malagola et al.
TRANSPLANTATION (2016)
Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells
Masahiro Hirakawa et al.
JCI INSIGHT (2016)
Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life
Yi-Chen Sun et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report
Paul J. Martin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report
Paul A. Carpenter et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Imatinib Mesylate for the Treatment of Steroid-Refractory Sclerotic-Type Cutaneous Chronic Graft-versus-Host Disease
Kristin Baird et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft-versus-Host Disease: Phase I Trial Results
Joseph Pidala et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
Stephanie J. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Madan H. Jagasia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Autologous platelet-rich plasma: evidence for clinical use
Claudia S. Cohn et al.
CURRENT OPINION IN HEMATOLOGY (2015)
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R. Zeiser et al.
LEUKEMIA (2015)
How we treat chronic graft-versus-host disease
Mary E. D. Flowers et al.
BLOOD (2015)
Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD
B. Frey Tirri et al.
BONE MARROW TRANSPLANTATION (2015)
A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft-versus-Host Disease
Alex F. Herrera et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Outcomes of Lung Transplantation after Allogeneic Hematopoietic Stem Cell Transplantation
Guang-Shing Cheng et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Randomized Double-Blind Clinical Trial Comparing Clobetasol and Dexamethasone for the Topical Treatment of Symptomatic Oral Chronic Graft-Versus-Host Disease
Cesar W. Noce et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: A dual center retrospective analysis
S. Mielke et al.
BONE MARROW TRANSPLANTATION (2014)
Guidelines on the use of extracorporeal photopheresis
R. Knobler et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease
Ae Ryoung Park et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2013)
Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease
Sarah Nikiforow et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Genital Chronic GVHD in Men after Hematopoietic Stem Cell Transplantation: A Single-Center Cross-Sectional Analysis of 155 Patients
Simon M. Mueller et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease
Yoshihiro Inamoto et al.
BLOOD (2013)
Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
Ken-ichi Matsuoka et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Randomized Trial of Hydroxychloroquine for Newly Diagnosed Chronic Graft-versus-Host Disease in Children: A Children's Oncology Group Study
Andrew L. Gilman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Organ-specific management and supportive care in chronic graft-versus-host disease
Fiona L. Dignan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Graft-versus-host disease Part II. Management of cutaneous graft-versus-host disease
Sharon R. Hymes et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease
Daniel Wolff et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease
Kathryn J. Martires et al.
BLOOD (2011)
Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD
G. C. Hildebrandt et al.
BONE MARROW TRANSPLANTATION (2011)
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
John Koreth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
First-Line Therapy for Chronic Graft-versus-Host Disease that Includes Low-Dose Methotrexate Is Associated with a High Response Rate
Yu Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease
Paul J. Martin et al.
BLOOD (2009)
Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT
K. Oda et al.
BONE MARROW TRANSPLANTATION (2009)
Therapy with mycophenolate mofetil for refractory acute and chronic GVHD
T. Furlong et al.
BONE MARROW TRANSPLANTATION (2009)
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease
Mary E. D. Flowers et al.
BLOOD (2008)
Phase II study of Pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease
David A. Jacobsohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Treatment of refractory chronic GVHD with rituximab: a GITMO study
F. Zaja et al.
BONE MARROW TRANSPLANTATION (2007)
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease
Silvia Svegliati et al.
BLOOD (2007)
Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
Alessandro Busca et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response Criteria Working Group report
SZ Pavletic et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease
E Zorn et al.
BLOOD (2005)
Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease
L Giaccone et al.
BONE MARROW TRANSPLANTATION (2005)
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease
DR Couriel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: Highly effective treatment with topical tacrolimus
A Eckardt et al.
ORAL ONCOLOGY (2004)
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone
S Koc et al.
BLOOD (2002)
Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment
A Nagler et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
Effective antigen presentation by dendritic cells is NF-κB dependent:: coordinate regulation of MHC, co-stimulatory molecules and cytokines
S Yoshimura et al.
INTERNATIONAL IMMUNOLOGY (2001)
Hydroxychloroquine for the treatment of chronic graft-versus-host disease
AL Gilman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease
F Carnevale-Schianca et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
Share Paper
